A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
PHASE1
The purpose of this study is to measure the safety, preliminary antitumor a...
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
PHASE1
This phase I trial tests zanubrutinib in combination with sonrotoclax for t...
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
PHASE2
This phase II trial studies the side effects of an escalated ramp-up of son...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium